In 2015 the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) informed DFSNZ about the results of Medsafe’s investigation into an internet drug supplier NZ Clenbuterol and provided DFSNZ details about the internet purchase in 2014 of prohibited substances made by the hockey player Richard Brougham.
Hereafter in June 2018 Drug Free Sport New Zealand (DFSNZ) has reported two anti-doping rule violations against Richard Brougham for the use, attempted use and possession of the prohibited substances Clenbuterol, Dianabol (Metandienone) and Nandrolone.
The Athlete gave a prompt admission, waived his right to be heard and accepted the sanction proposed by DFSNZ. He stated that he purchased the substance Clenbuterol and denied the purchase and payment for Nandrolon and Metandienone.
The parties in this case reached an agreement and filed a joint memorandum in relation to the sanction for approval into a decision of the Sports Tribunal of New Zealand.
The Sports Tribunal of New Zealand considers that the Athlete gave a prompt admission and that there were substantial delays in the proceedings not attributed to the Athlete.
Therefore the Sports Tribunal of New Zealand decides on 20 July 2018 to impose a 2 year period of ineligibility on the Athlete starting backdated by 10 months from 20 September 2017.
